No Data
No Data
Chieru: FY March 2024 Financial Results Presentation Materials
Stocks that moved the previous day include Ridge-i, Pharmafoods, and Tokyo Seimitsu, among others.
Stock name <code> 11th closing price ⇒ Previous day comparison Chier <3933> 558 + 17 Announced financial estimates for the FY2025 March term increase. Nittomou <3524> 1618 + 1382 The operating profit forecast for the FY2024 April term has been downwardly revised, but the revenue, ordinary profit, and net profit forecasts have been upwardly revised. B & P <7804> 1647 -127 The growth rate has decreased as the operating profit for the first half of the year increased by 15.9% from 2.8 times the first quarter. VEGA <3542> 677 -265 Sales for the month decreased by 17.7%. Japan Information C.
Active and newly established stocks in the afternoon session.
*Chiel <3933> announced in 1725 that it is expecting an increase in dividends for the fiscal year ending March. *Nitto-mou <3524> expects a downward revision of operating profit for the fiscal year ending April 2018, but an upward revision of expected revenue, ordinary profit, and net profit. *B & P <7804> saw a decrease in profit growth rate from 15.9% increase in operating profit in the first half to 2.8 times in the first quarter. *VEGA <3542> had a 17.7% decrease in revenue in the month. *Nippon Information <4054> +607
Investment Strategy for June 11th [today].
[FISCO selected stocks] [Material stocks] Pharmafoods <2929> 862 yen (6/10) Mainly engaged in supplement and cosmetic e-commerce. Also handles functional materials. Announced third quarter results. Cumulative operating profit was 3.266 billion yen (a 99.9% increase over the same period last year). Profit increased from 1.535 billion yen in the first half. At the same time, it strengthened advertising and publicity for new products while optimizing overall advertising and publicity expenses. Operating profit for the July 2024 period is expected to be 2.7 billion yen (a 25.2% decrease from the previous period) until the third quarter.
Pay attention to Kurazushi and PharmaF, while B Garage and Altona may be sluggish.
On September 10th, in the US stock market, the Dow Jones Industrial Average rose 69.05 dollars to 38,868.04, and the Nasdaq Composite Index rose 59.40 points to 17,192.53. The Chicago Nikkei 225 futures on the Osaka Day Return increased by 185 yen to 39,185 yen. The exchange rate is 1 dollar = 157.00-10 yen. In today's Tokyo market, Pharma F <2929> reported a cumulative operating profit increase of 99.9% for the third quarter, while Kura Sushi <2695> raised its fiscal 2024 revenue and operating profit estimates for the period ending in October.
Kura Sushi upwardly revised its operating profit to 5.5 billion yen from 2.4 billion yen on October 24th.
Kura Sushi <2695> announced revisions to its earnings forecast for the fiscal year ending 2024/10. Sales were revised upward from 226.2 billion yen to 234 billion yen, and operating profit was revised upward from 2.4 billion yen to 5.5 billion yen. It exceeds the upper consensus level (about 5.1 billion yen). The domestic business was in a difficult situation due to rising purchase prices, rising labor costs, utility costs, etc., but fairs centered on high-quality products such as “tuna” and “crab,” which are the company's strengths, and the hugely popular character “Chikawa” and movie versions
No Data